Showing results filtered by:
9 Results
NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.
Published: February 15, 2023
Sample Application (F31): Putnam
https://www.niaid.nih.gov/sites/default/files/nicoleputnamapplicationF31.pdf
Last Reviewed: January 25, 2023
Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020
https://www.niaid.nih.gov/sites/default/files/ORWH-Biennial-Report2019-20.pdf
Last Reviewed: March 8, 2022
NIAID DIR 2022 Opportunities Book
https://www.niaid.nih.gov/sites/default/files/2022_DIR_opps_book_QR_sm.pdf
Last Reviewed: November 3, 2022
The Jordan Report: Accelerated Development of Vaccines 2007
https://www.niaid.nih.gov/sites/default/files/jordan2007.pdf
Last Reviewed: August 6, 2019
NIH Request for Information on a Strategic Framework for Tuberculosis Research
https://www.niaid.nih.gov/sites/default/files/TBRFIAnalysisReport.pdf
Last Reviewed: September 26, 2018
Summary of the NIAID Expert Panel on Botulinum Diagnostics, May 23, 2003
https://www.niaid.nih.gov/sites/default/files/bot_toxins_mtg.pdf
Last Reviewed: May 23, 2003
The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public
Last Reviewed: January 11, 2024
The 206 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Tuesday, January 30, 2024. Dr. Jeanne Marrazzo, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:45 a.m. and from 1
Last Reviewed: May 21, 2024